TY - JOUR
KW - buprenorphine
KW - HIV/AIDS
KW - Naltrexone
KW - opioid dependence
KW - Randomized Clinical Trial
AU - A. Mokri
AU - M. C. Chawarski
AU - H. Taherinakhost
AU - R. S. Schottenfeld
A1 - 
BT - Addiction (Abingdon, England)
C5 - Opioids & Substance Use
CP - 5
CY - England
DO - 10.1111/add.13259
IS - 5
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2016
SN - 1360-0443; 0965-2140
SP - 874
EP - 882
EP - 
T1 - Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment
T2 - Addiction (Abingdon, England)
TI - Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment
U1 - Opioids & Substance Use
U2 - 26639678
U3 - 10.1111/add.13259
VL - 111
VO - 1360-0443; 0965-2140
Y1 - 2016
ER -